- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05127993
Comprehensive Evaluation of the Passive Talaris Demonstrator
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Twenty-eight healthy active participants with an unilateral transtibial amputation will conduct 2 experimental trials (EXP1 & EXP2) on the same day in a randomized order, i.e. EXP1 with the currently used prosthesis and EXP2 with the passive Talaris Demonstrator. Each experimental trial will include 6 minutes of treadmill walking at 3 different speeds in consecutive blocks of 2 minutes, a slope walking test, a stair climbing test, a L-test and an outdoor walking task.
The six minutes walk test (6MWT) has become one of the most widely used performance-based outcome measures of functional mobility and exercise capacity. Recently, the 6MWT has been found to correlate with single-limb balance time and symmetry of step length in people with amputation. Additionally, the 6MWT distance has been shown to be responsive to functional training interventions in people with lower-limb amputation. Six minutes of treadmill walking at 3 different speeds will be performed. This test will be performed in consecutive blocks of 2 minutes. These consecutive blocks will be walking 2 minutes at self-selected (SS) speed, 2 minutes at 75% of the SS speed and 2 minutes at 125% of the SS speed. These different walking speeds elicit different angular positions of the ankle and activation levels of muscles, and thus might alter the effectiveness of the novel device.
The slope walking test assesses the participants' ability to ascend and descend a 6 m long ramp of 10% inclination as fast as possible. For safety reasons bilateral handrails are warranted. Participants start the test in an upright position in front of the ramp and are asked to ascend the ramp, turn around on the platform, descend the ramp and return to the starting position.
The stair climbing test assesses the participants' ability to ascend and descend a staircase (84 cm total height, 3-step staircase with an average rise of 28 cm and run of 18 cm). Participants start in front of the staircase and are asked to ascend and descend as fast as possible. Again, bilateral handrails are required to allow support when needed. The ascending phase is initiated with the prosthetic side, while the first step of the descending phase is performed with the non-involved leg.
The L-test, requires higher physical activity of the user. During the L-test, participants are asked to rise from a chair, walk 7 meters, turn 90 degrees, walk 3 meters, turn 180 degrees and then return in the same way to the seated position. A total distance of 20 meter is covered.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Brussels, Belgique, 1050
- Vrije Universiteit Brussel
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Unilateral transtibial (below knee) amputation
- Unilateral transfemoral (above knee) amputation
- Healthy subject
- Medicare Functional Classification Level: K2-4
Exclusion Criteria:
- Any neurological disease
- Upper limb or bilateral amputation
- Stump pain or bad fit of the socket
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Novel prosthesis
A unilateral transtibial amputee will conduct experiments with the novel prosthesis followed by experiments with the current prosthesis.
|
The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by "Axiles Bionics".
|
|
Comparateur actif: Current prosthesis
A unilateral transtibial amputee will conduct experiments with the current prosthesis followed by experiments with the novel prosthesis.
|
The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by "Axiles Bionics".
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Performance
Délai: Through study completion, a period of 4 months
|
Heart rate during all tasks
|
Through study completion, a period of 4 months
|
|
Performance
Délai: Through study completion, a period of 4 months
|
Time needed to perform the L-test
|
Through study completion, a period of 4 months
|
|
Performance
Délai: Through study completion, a period of 4 months
|
Speed during 6 minutes walk test
|
Through study completion, a period of 4 months
|
|
Physiological
Délai: Through study completion, a period of 4 months
|
Electromyography: lower limb muscle activity during different movements (% of the MVC)
|
Through study completion, a period of 4 months
|
|
Physiological
Délai: Through study completion, a period of 4 months
|
Oxygen consumption during stair climbing, slope walking and during the 6 minutes walk test
|
Through study completion, a period of 4 months
|
|
Psychological
Délai: Through study completion, a period of 4 months
|
Visual analogue scale for comfort (score: 0= not comfortable, 100 = comfortable) and fatigue (score: 0= not fatiguing, 100 = fatiguing) during all tasks
|
Through study completion, a period of 4 months
|
|
Biomechanical
Délai: Through study completion, a period of 4 months
|
Joint angels and joint angular velocities of hip, knee and ankle joints
|
Through study completion, a period of 4 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Kevin De Pauw, Vrije Universiteit Brussel
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- BUN143201526629
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .